3D Printed Drugs Market

3D Printed Drugs Market by Dosage Form (Tablet, Capsule, Nanoparticles), Technology (Inkjet Printing, Zipdose, Direct Write, Stereolithography, Fused Deposition Modeling), Application (Orthopedic, Neurology, Dental) - Global Forecast to 2027

Report Code: UC 6075 Dec, 2024, by marketsandmarkets.com

The global 3D Printed Drugs market is projected to reach USD 110 million by 2027 from ~USD 50 million in 2022, at a CAGR of 17% during the forecast period

To know about the assumptions considered for the study, Request for Free Sample Report

3D printed drugs have ability to form a definite 3D structure with a precise and unique dosages for individual patients to present more efficient drug administration. 3D printing tool allows small-scale production of medicines by using approach of 3D modeling software to build an object layer-by-layer for solid drugs. By adjusting the printing parameters, the dosages, drug combinations and flavors can be personalized. US Food and Drug Administration (US FDA) approved first 3D printed drug Spritam to treat epilepsy symptoms in 2015.

This Market is expected to witness lucrative growth during next five years. The growth of this market is driven by factors such as increasing adoption of personalized drugs, growing research and development activities, increasing disease prevalence, increasing availability of individual drugs and the production of combination medications. However, the usage of 3D printing to develop illegal drugs restrains the growth of the market.

The 3D printed drugs market is categorized on the basis of dosage form, technology, application and region. Based on dosage form, the 3D printed drugs market is segmented into tablets, capsules, multi drug implants, nanoparticles, solutions, and other dosage forms. At present, 3D printed drugs are available only in the form of tablets in the market. However, the other dosage forms are likely to be commercialized in the coming years. On the basis of technology, the 3D printed drugs market is segmented into inkjet printing, direct write, zip dose, thermal inkjet printing, fused deposition modeling, powder bed printing, stereolithography (SLA), and semi solid extrusion (SSE). On the basis of application, the 3D printed drugs market is segmented into neurology, orthopedic, dental and other applications segments. Based on the region, the market is divided into North America, Europe, Asia Pacific and Rest of World region.

To know about the assumptions considered for the study, download the pdf brochure

The report is a comprehensive study of current market trends, industry growth drivers, restraints, opportunities and challenges. The exhaustive regional and country level 3D printed drugs market analysis is provided for 2020-2027. Each market is comprehensively analysed at a granular level to provide in-depth information.

The 3D printed drugs market is dominated by a few globally established players such as Aprecia Pharmaceuticals LLC (US), Bioduro (US), Acrux (US), AstraZeneca (UK), Biomedical modeling Inc. (US), GlaxoSmithKline Plc (UK), Merck KGaA (Germany), Cycle Pharmaceuticals (UK), among others.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TABLE OF CONTENTS

1 INTRODUCTION
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS & EXCLUSIONS
    1.3 MARKET SCOPE
           1.3.1 MARKET COVERED
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
    1.5 LIMITATIONS
    1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY
    2.1 RESEARCH DATA
           2.1.1 SECONDARY DATA
           2.1.2 PRIMARY DATA
                    2.1.2.1 Key industry insights
    2.2 MARKET SIZE ESTIMATION
    2.3 MARKET GROWTH RATE PROJECTIONS
    2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
    2.5 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           5.2.1 DRIVERS
           5.2.2 RESTRAINTS
           5.2.3 OPPORTUNITIES
           5.2.4 CHALLENGES
    5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
    5.4 PRICING ANALYSIS
    5.5 VALUE CHAIN ANALYSIS
    5.6 ECOSYSTEM ANALYSIS
    5.7 PATENT ANALYSIS
    5.8 KEY CONFERENCES AND EVENTS IN 2022-2023
    5.9 REGULATORY ANALYSIS
    5.10 PORTER’S FIVE FORCES ANALYSIS
    5.11 KEY STAKEHOLDER AND BUYING CRITERIA

6 3D PRINTED DRUGS MARKET, BY DOSAGE FORM, 2020-2027 (USD MILLION)
    6.1 INTRODUCTION 
    6.2 TABLET
    6.3 CAPSULE
    6.4 MULTIDRUG IMPLANT
    6.5 NANOPARTICLES
    6.6 SOLUTIONS
    6.7 OTHER PRODUCTS (IF ANY)

7 3D PRINTED DRUGS MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
    7.1 INTRODUCTION
    7.2 INKJET PRINTING
    7.3 DIRECT WRITE
    7.4 ZIP DOSE
    7.5 THERMAL INKJET PRINTING 
    7.6 FUSED DEPOSITION MODELLING
    7.7 POWDER BED PRINTING
    7.8 STEREOLITHOGRAPHY (SLA)
    7.9 SEMI SOLID EXTRUSION (SSE)

8 3D PRINTED DRUGS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    8.1 INTRODUCTION
    8.2 ORTHOPEDIC
    8.3 NEUROLOGY
    8.4 DENTAL 
    8.5 OTHERS (IF ANY)

9 3D PRINTED DRUGS MARKET, BY REGION, 2020-2027 (USD MILLION)
    9.1 INTRODUCTION
    9.2 NORTH AMERICA
           9.2.1 US
           9.2.2 CANADA
    9.3 EUROPE
           9.3.1 GERMANY
           9.3.2 FRANCE
           9.3.3 UK
           9.3.4 ITALY
           9.3.5 SPAIN
           9.3.6 ROE
    9.4 ASIA PACIFIC
           9.4.1 JAPAN
           9.4.2 CHINA
           9.4.3 INDIA
           9.4.4 REST OF APAC
    9.5 REST OF THE WORLD (ROW)
           9.5.1 LATIN AMERICA
           9.5.2 MIDDLE EAST & AFRICA

10 COMPETITIVE LANDSCAPE
     10.1 OVERVIEW
     10.2 KEY PLAYER STRATEGIES
     10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
     10.4 MARKET SHARE ANALYSIS, 2021
     10.5 COMPANY EVALUATION QUADRANT
     10.6 COMPANY EVALUATION QUADRANT – SME/START-UPS
     10.7 COMPANY GEOGRAPHIC FOOTPRINT
     10.8 COMPETITIVE SCENARIO

11 COMPANY PROFILES
     11.1 APRECIA PHARMACEUTICALS, LLC
     11.2 FABRX LTD
     11.3 CYCLE PHARMACEUTICALS
     11.4 GLAXOSMITHKLINE PLC.
     11.5 ASTRAZENECA
     11.6 TVASTA
     11.7 MERCK KGGA
     11.8 TERUMO CORPORATION
     11.9 EXTEND BIOSCIENCES
     11.1 BIODURO
     11.11 AFFINITY THERAPEUTICS
     11.12 TVASTA
     11.13 OSMOTICA PHARMACEUTICALS

* Company profiles of 25 players will be provided in this section. This section will include Business Overview, Products Offered, Recent Developments, MnM View. Kindly note that the financial analysis and MnM View might not be captured in case of unlisted companies.

12 APPENDIX
     12.1 INSIGHTS FROM INDUSTRY EXPERTS
     12.2 DISCUSSION GUIDE
     12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
     12.5 AVAILABLE CUSTOMIZATIONS
     12.6 RELATED REPORTS
     12.7 AUTHOR DETAILS


Request for detailed methodology, assumptions & how numbers were triangulated.

Please share your problem/objectives in greater details so that our analyst can verify if they can solve your problem(s).
8 1 0 0 4  
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization
Report Code
UC 6075
Available for Pre-Book
Choose License Type
Prebook Now
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the 3D Printed Drugs Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
knowledgestore logo

Want to explore hidden markets that can drive new revenue in 3D Printed Drugs Market?

Find Hidden Markets
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status
Website Feedback